Denise Bevers, Director at Kindred Biosciences, Inc. (KIN), sold 8,396 shares at $5.00 ($42K) on 2021-03-17, disclosed to the SEC on 2021-03-18.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KIN | SELL | 2021-01-08 | $195K | — | Filing → |
| KIN | SELL | 2020-10-08 | $125K | — | Filing → |
| KIN | SELL | 2020-09-24 | $3K | — | Filing → |